Location History:
- Rutland, MA (US) (2015)
- Boylston, MA (US) (2016 - 2023)
Company Filing History:
24 out of 37 
3 out of 7 
1 out of 192 
Years Active: 2015-2025
Title: **Rangaprasad Sarangarajan: Innovator in Drug Toxicity and Disease Modeling**
Introduction
Rangaprasad Sarangarajan, based in Boylston, MA, is a prominent inventor with an impressive portfolio of 24 patents to his name. His work primarily focuses on the field of drug toxicity and disease modeling, showcasing his contributions to advancing medical science and pharmaceuticals.
Latest Patents
Among his latest innovations, Sarangarajan has developed a groundbreaking platform technology for analyzing drug-induced toxicity conditions. One of his patents is titled "Interrogatory cell-based assays for identifying drug-induced toxicity markers." This invention focuses on analyzing conditions such as cardiotoxicity through model building. Another notable patent is "Interrogatory cell-based assays and uses thereof," which describes a similar platform technology aimed at analyzing biological systems or processes, including disease conditions like cancer.
Career Highlights
Rangarprasad is currently employed at Berg LLC, a company dedicated to pioneering scientific advancements in human health. His inventive approach and expertise have greatly contributed to the company's mission of transforming the way diseases are understood and treated.
Collaborations
Throughout his career, Sarangarajan has collaborated with esteemed colleagues such as Niven Rajin Narain and Vivek Kannoth Vishnudas. These partnerships highlight the collaborative spirit within the scientific community, fostering an environment where groundbreaking discoveries can take place.
Conclusion
Rangaprasad Sarangarajan stands out as a key figure in the field of innovation, particularly in drug toxicity and disease modeling. His extensive patent portfolio not only underscores his expertise but also his commitment to enhancing healthcare through scientific innovation.